Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)
The Top Line
Advancements in Gene Editing Therapies and Cell Manufacturing for Heart Patients
Exploration of the progress in gene editing therapies, challenges in scaling up these treatments, and the development of a manufacturing platform for regenerative cell therapy in late-stage trials for post-myocardial infarction patients. Results of clinical studies in France and the UK show promising outcomes in improving heart function, paving the way for potential phase three trials in the US and Europe.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
